US equities |
MU $1,045.56 ▲+0.00% INTC $112.50 ▲+0.00% SNDK $1,660.46 ▲+0.00% NVDA $239.24 ▲+0.00% SPCX $171.92 ▲+0.00% MRVL $287.01 ▲+0.00% AMD $649.42 ▲+0.00% MSTR $164.55 ▲+0.00%
FinancialContent

Latest News about XNAS:RNXT

Recent news which mentions XNAS:RNXT

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
Tickers IMU RNXT
Tags XNAS:RNXT RenovoRx, Inc
From TheNewswire.com - RSS (Media)
RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform
Tickers RNXT
Tags RenovoRx Inc XNAS:RNXT
From TheNewswire.com - RSS (Media)
RenovoRx’s Principal Investigator of Phase III Clinical Trial Discusses Positive Interim Results on Patients with Locally Advanced Pancreatic Cancer on OncologyTube
Tags XNAS:RNXT TalkMarkets
From TheNewswire.com - RSS (Media)